Company announcement - No. 7 / 2025 Resolutions from Zealand Pharma's Annual General Meeting 2025 Copenhagen, Denmark, March 27, 2025 - Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL) (CVR-no. 20045078) ...

The global anti-inflammatory therapeutics market size was US$ 94,511 million in 2021. The global anti-inflammatory therapeutics market is forecast to grow to US$ 130,711.1 million by 2030 by ...

Viking Therapeutics VKTX announced that it has completed enrolling study participants in the phase II VENTURE-Oral Dosing ...

The global Pharmaceutical Manufacturing Market was valued at US$ 859.5 billion in 2023 and is projected to reach market size of US$ 2,301.6 billion by 2032 at a CAGR of 11.56% during the forecast ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report), ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying ...

Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Comcast Corp.

Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also ...

Novo Nordisk already has a fairly well-stocked pipeline of candidates, but one of its near-term hopes – CagriSema, which combines semaglutide with dual amylin and calcitonin receptor agonist ...

AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...